XGN
Companies
NASDAQ
Exagen Inc.
Health Care
$7.06
+$2.96 (+72.20%)
Price Chart
Overview
About XGN
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
Market Cap
$35.1M
Volume
3.5M
Avg. Volume
1.8M
P/E Ratio
-7.2409644
Dividend Yield
0.00%
Employees
205.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.56
High Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, XGN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$35.1M
Volume3.5M
P/E Ratio-7.24
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 5, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025